RE: IQAI1 Oct 2019 19:12
David Smith, Chief Executive of the operating subsidiaries of IQ-AI stated, "We are delighted that after an exhaustive review of the product, that the FDA has cleared the product for marketing in the USA."
A further announcement will be issued in the next few days, outlining the scale of the market opportunity for the product in the USA and IQ-AI's plans for introduction.
So we are hit with a placing and not the deals that were mentioned in last weeks fda rns. Smacks of mates rates bit of a joke really is this what the market has boiled down to with scratch your back deals for any company to get anywhere in this upside down world....